• Skip to main navigation
  • Skip to search
  • Skip to main content
Vrije Universiteit Brussel Home Vrije Universiteit Brussel Logo
  • Help & FAQ
    • English
    • Nederlands
  • Home
  • Research Units
  • Profiles
  • Projects
  • Research output
  • Activities
  • Equipment
  • Prizes
  • Press / Media
  • Student theses
  • Datasets
  • Impacts

Nanobody-mediated imaging of the immune checkpoint LAG-3

Lecocq, Q. (Speaker), Zeven, K. (Contributor), De Vlaeminck, Y. (Contributor), Martens, S. (Contributor), Massa, S. (Contributor), Goyvaerts, C. (Contributor), Raes, G. (Contributor), Keyaerts, M. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor)
  • Basic (bio-) Medical Sciences
  • Faculty of Medicine and Pharmacy
  • Supporting clinical sciences
  • https://lmmo.research.vub.be/en/home
  • Experimental Pathology
  • Pathology/molecular and cellular medicine
  • Department of Bio-engineering Sciences
  • Cellular and Molecular Immunology
  • Medical Imaging
  • https://lmct.research.vub.be/
  • Nuclear Medicine

Activity: Talk or presentation › Talk or presentation at a conference

Period18 Oct 2019
Event titleORC day 2019
Event typeConference
Degree of RecognitionNational

Related content

  • Projects

  • Translational & Clinical Research : Visualizing immunosuppressive PD-L1 expression in tumors using anti­ PD-L1 sdAb PET-CT scan: a new strategy for accurate patient selection in targeted immune-activating cancer therapy

    Project: Fundamental

  • FWO Hercules MZW: Platform for cell analysis after radioactivity based Molecular Imaging and targeted Therapy of cancer (PeRMIT)

    Project: Fundamental

  • Nanobody-mediated imaging and blocking of the inhibitory receptor LAG-3

    Project: Fundamental

  • The visualization of immunosuppressive PD-L1 expression by means of anti-PD-L1 Nanobody PET-CT scan: a new strategy for the accurate patient selection in immuno-activating oncological treatment

    Project: Fundamental

Powered by Pure, Scopus & Elsevier Fingerprint Engine™ © 2023 Elsevier B.V.

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

Log in to Pure

Vrije Universiteit Brussel data protection policy

About web accessibility

Contact us